Spearhead Capital Advisors, LLC Coherus Bio Sciences, Inc. Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$10.92 - $16.41 $280,840 - $422,032	-25,718 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$15.81 - $18.99 $4,711 - $5,659	298 Added 1.17%	25,718 $410,000
Q3 2021 Oct 27, 2021	SELL	$12.68 - $17.79 $2,383 - $3,344	-188 Reduced 0.73%	25,420 $408,000
Q2 2021 Aug 10, 2021	BUY	$12.95 - $15.41 $54,118 - $64,398	4,179 Added 19.5%	25,608 $354,000
Q1 2021 Apr 28, 2021	BUY	$14.42 - $21.39 $309,006 - $458,366	21,429 New	21,429 $313,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.